LARYNGECTOMY ALONE FOR T3 GLOTTIC CANCER

被引:33
作者
FOOTE, RL
OLSEN, KD
BUSKIRK, SJ
STANLEY, RJ
SUMAN, VJ
机构
[1] MAYO CLIN & MAYO FDN,DIV RADIAT ONCOL,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT OTORHINOLARYNGOL,ROCHESTER,MN 55905
[3] MAYO CLIN & MAYO FDN,BIOSTAT SECT,ROCHESTER,MN 55905
[4] MAYO CLIN JACKSONVILLE,DEPT RADIAT ONCOL,JACKSONVILLE,FL
[5] DEAN CLIN,DEPT OTORHINOLARYNGOL,MADISON,WI
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 1994年 / 16卷 / 05期
关键词
D O I
10.1002/hed.2880160503
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The long-term survival of 81 patients with T3 squamous cell carcinoma of the glottic larynx treated with laryngectomy alone is presented and pathologic predictors for cancer recurrence above the clavicles and cancer death are identified. Methods. Clinical records, operative notes, and pathologic slides were reviewed. The major end points were failure above the clavicles, cause-specific survival, and overall survival. All patients were followed until death or a minimum of 10.8 years. Results. The main pattern of treatment failure was within an undissected ipsilateral or contralateral neck. Subglottic extension and nodal metastases predicted failure above the clavicles and delayed metastasis within an undissected neck. The 5-year rate of control of disease above the clavicles, cause-specific survival, and overall survival were 74.1%, 73.7%, and 54.3%, respectively. Conclusions. Patients treated with laryngectomy for T3 glottic cancer who have pathologic evidence of subglottic extension or nodal metastasis are at higher risk for recurrence above the clavicles, particularly within an undissected neck. (C) 1994 John Wiley & Sons, Inc.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 40 条
[1]  
[Anonymous], 1991, NEW ENGL J MED, V324, P1685
[2]  
BILLER HF, 1986, LARYNGOSCOPE, V96, P61
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]  
CROLL GA, 1989, EUR J SURG ONCOL, V15, P350
[5]  
DESANTO LW, 1984, LARYNGOSCOPE, V94, P1311
[6]  
FOOTE RL, 1989, CANCER, V64, P143, DOI 10.1002/1097-0142(19890701)64:1<143::AID-CNCR2820640124>3.0.CO
[7]  
2-I
[8]  
GILBERT RW, 1985, ARCH OTOLARYNGOL, V112, P856
[9]   MANAGEMENT OF ADVANCED GLOTTIC CANCER - 10-YEAR-REVIEW OF THE TORONTO EXPERIENCE [J].
HARWOOD, AR ;
HAWKINS, NV ;
BEALE, FA ;
RIDER, WD ;
BRYCE, DP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (06) :899-904
[10]  
HARWOOD AR, 1981, CANCER-AM CANCER SOC, V47, P367, DOI 10.1002/1097-0142(19810115)47:2<367::AID-CNCR2820470226>3.0.CO